Stay updated on Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Sign up to get notified when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.

Latest updates to the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor page version update. This change reflects a maintenance update rather than a substantive change to the study details.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays Revision: v3.6.2 in the site footer, indicating a recent site release. This update appears to be a deployment or UI refresh rather than changes to trial content.SummaryDifference0.1%

- Check32 days agoChange DetectedA new recruitment status note 'No longer looking for participants' has been added, indicating enrollment is closed. New guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were introduced, the 'Intervention/Treatment' header was standardized, and the page revision was updated to v3.6.0.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing v3.5.4, signaling a new version of the page. This change is a metadata/versioning update rather than a modification to the study content or results.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision tag updated to v3.5.4, indicating a newer version of the study record.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed site revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform/release update without changing the underlying study details.SummaryDifference0.1%

Stay in the know with updates to Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.